Scientists have developed a new systematic review to summarize for neurologists and other clinicians the evidence for epidural steroid injections and whether they reduce pain and disability for people ...

There appears to be limited evidence supporting the use of epidural steroid injections for certain types of chronic lower ...

Researchers found that epidural steroid injections may modestly reduce pain and disability in patients with a pinched nerve ...

Epidural steroid injections may modestly reduce pain and disability for certain chronic back pain conditions, but their ...

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...

Epidural steroid injections demonstrated limited efficacy in reducing back pain and disability, according to a systematic ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and full year ended December 31, 2024, and provided ...

The global paresthesia treatment market is growing due to rising neurological disorders, tech advancements, and demand for ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

H.C. Wainwright analyst Andrew Fein increased the price target for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) to $550 from the previous $535, while maintaining a Buy rating on the stock.